SHV Hyperproduction as a Mechanism for Piperacillin–Tazobactam Resistance in Extended-Spectrum Cephalosporin-Susceptible Klebsiella pneumoniae
- 10 April 2020
- journal article
- research article
- Published by SAGE Publications in Microbial Drug Resistance
- Vol. 26 (4) , 334-340
Abstract
This study aimed to determine the mechanism of resistance to piperacillin–tazobactam (TZP) in Klebsiella pneumoniae bloodstream isolates that are susceptible to extended-spectrum cephalosporins (ESCs). Antibiotic susceptibility was determined for K. pneumoniae isolated from children with bacteremia. The β-lactamase genes were detected using a large-scale bla detection method ( LARGE-SCALE bla Finder) and confirmed by sequencing analysis. The isolates were further characterized by β-lactamase activity assays and multilocus sequence typing. Among the 300 bloodstream isolates of K. pneumoniae , 11 (3.7%) were TZP resistant but ESC susceptible. The TZP minimum inhibitory concentrations (MICs) of the isolates ranged from 128/4 to >2,048/4 mg/L. Avibactam markedly inhibited piperacillin resistance, reducing the MICs to the range of ≤1 to 8 mg/L. Among the 11 isolates, four hyperproduced SHV-1 and two hyperproduced SHV-11, exhibiting 77- to 496-fold higher β-lactamase activity compared with the SHV-1- and SHV-11-producing reference strains that are susceptible to TZP. OXA-1 was coproduced in three isolates, and the remaining two isolates produced TEM-30. Transformants with recombinant plasmids carrying the β-lactamase genes demonstrated an increase in MICs of TZP. The TZP-resistant and ESC-susceptible isolates were not epidemiologically related. Hyperproduction of SHV-1 and SHV-11 represents a novel mechanism for reducing TZP activity in K. pneumoniae isolates resistant to ESCs. Continuous monitoring and investigation of TZP-resistant isolates are needed in the current era of high TZP consumption.Keywords
This publication has 37 references indexed in Scilit:
- Avibactam is a covalent, reversible, non–β-lactam β-lactamase inhibitorProceedings of the National Academy of Sciences, 2012
- Spanish Multicenter Study of the Epidemiology and Mechanisms of Amoxicillin-Clavulanate Resistance in Escherichia coliAntimicrobial Agents and Chemotherapy, 2012
- Three Decades of β-Lactamase InhibitorsClinical Microbiology Reviews, 2010
- Plasmid-borne blaSHV genes in Klebsiella pneumoniae are associated with strong promotersJournal of Antimicrobial Chemotherapy, 2009
- IRT and CMT β-lactamases and inhibitor resistanceClinical Microbiology and Infection, 2008
- Extended-Spectrum β-Lactamases: a Clinical UpdateClinical Microbiology Reviews, 2005
- Multilocus Sequence Typing of Klebsiella pneumoniae Nosocomial IsolatesJournal of Clinical Microbiology, 2005
- Mechanisms of reduced susceptibility to amoxycillin-clavulanic acid in Escherichia coli strains from the health region of Tortosa (Catalonia, Spain)Clinical Microbiology and Infection, 2004
- Outer membrane protein change combined with co-existing TEM-1 and SHV-1 beta-lactamases lead to false identification of ESBL-producing Klebsiella pneumoniaeJournal of Antimicrobial Chemotherapy, 2001
- RESISTANCE TO BETA-LACTAM/CLAVULANATEThe Lancet, 1987